by Jordana Choucair | Dec 10, 2021 | Life Sciences
The FDA authorized the Pfizer/BioNTech COVID-19 vaccine booster shots for people ages 16 and 17. Just as with adults, 16- and 17-year-olds are eligible to receive a booster dose six months after their second dose of the Pfizer/BioNTech vaccine. CDC Director Dr....
by Jordana Choucair | Dec 9, 2021 | Life Sciences
The FDA authorized the first widely available drug to help prevent COVID-19 among people with vaccine allergies and those with weakened immune systems, for whom the shots may not be effective. The drug from AstraZeneca PLC is expected to offer longer-lasting...
by Jordana Choucair | Dec 8, 2021 | Life Sciences
Pfizer Inc.-BioNTech SE announced that a third dose of their COVID-19 vaccine neutralized the omicron variant and raised antibodies 25-fold in initial lab studies. While the companies said the results offer reassurance that the current formulations will protect...
by Jordana Choucair | Dec 7, 2021 | Life Sciences
USAID said it is launching a new $400 million program to help speed COVID-19 vaccinations in lower-income countries. Most of the funding will go toward helping the countries with policy, supply chain logistics, and administering the shots in remote areas. The rest...
by Jordana Choucair | Dec 7, 2021 | Life Sciences
GlaxoSmithKline Plc said research shows its COVID-19 antibody treatment is effective against the full combination of mutations in the new omicron variant. Tests done in-vitro against a pseudo-virus that recreates a synthesized version of omicron showed that...
by Jordana Choucair | Dec 3, 2021 | Life Sciences
The FDA is preparing to accelerate the review of vaccines and drugs targeting the omicron variant in case they’re needed. According to people familiar with the matter, agency officials are meeting with drugmakers and establishing guidelines for research. Vaccine...
Recent Comments